Clinical Trials Logo

Clinical Trial Summary

Acute Aortic Syndrome (AAS) is a potentially life-threatening cause of sudden, severe chest pain. There are several possible underlying causes, which cannot be distinguished from one another at the bedside.

Current practice is to image this with two CT scans of the chest, one before injection of a contrast dye into the blood stream and then one after.

With the advancement of CT scanner technology, improvements in software interpretation and screen resolution, the investigators hypothesise that performing the contrast scan on its own is diagnostically equivalent to both the pre- and contrast scans


Clinical Trial Description

AAS include: a tear in the wall of the main artery from the heart, bleeding directly into this wall, an ulcer in the wall, and excess dilatation and rupture of the main artery wall. These are also treated differently according to where they are in the length of the aorta. It is therefore important to identify precisely the subtype of AAS and its location to allow the clinician to manage the patient appropriately.

Current practice is to image this with two CT scans of the chest, one before injection of a contrast dye into the blood stream and then one after. The one before the contrast is used to determine if there is bleeding within the wall, which would show up as white on this scan. It is currently accepted that the contrast in the artery itself would hide the presence of bleeding within the wall. The other causes are seen primarily on the contrast scan only. Every patient proceeds from the pre-contrast scan to the contrast scan, unless there is a contraindication to the intravenous dye.

The investigators own database search has shown that radiologists protocol the scans according to their own preference and experience (i.e. some do both scans, others the contrast scan only). There is conflicting advice from international professional bodies as to whether to perform the non-contrast scan every time.

Some studies have shown that although the pre-contrast scan is sensitive to picking up bleeding within the wall, it adds nothing more over an increased radiation dose to the patient.

The investigators hypothesise that performing the contrast scan on its own is diagnostically equivalent to both the pre- and contrast scans to look for all 4 of these entities that make up AAS. The investigators also propose that not requiring the pre-contrast scan would have significant savings in patient radiation dose, scanner time, network resources and radiologist time. ;


Study Design

Observational Model: Cohort, Time Perspective: Retrospective


Related Conditions & MeSH terms


NCT number NCT02273245
Study type Observational
Source Plymouth Hospitals NHS Trust
Contact
Status Completed
Phase N/A
Start date January 2015
Completion date October 2015

See also
  Status Clinical Trial Phase
Completed NCT03647566 - 18F Sodium Fluoride PET/CT in Acute Aortic Syndrome
Recruiting NCT05965453 - Evaluation of the Castor Single Branch Stent Graft in Treatment of Acute Aortic Syndrome
Recruiting NCT05339529 - Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Thymosin α1) V N/A
Recruiting NCT06277895 - VOCs in Patients With Acute Cardiogenic Chest Pain N/A
Recruiting NCT04699279 - Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Rosuvastatin) I N/A
Completed NCT04711889 - Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Ulinastatin) II N/A
Enrolling by invitation NCT04398992 - Additive Anti-inflammatory Action for Aortopathy & Arteriopathy
Completed NCT04751058 - Genetic Profile in Patients With Aortic Syndrome
Completed NCT04430400 - Integrated Diagnostic Algorithm for Acute Aortic Syndromes
Completed NCT01259843 - French National Observatory of Aortic Syndromes